Next Article in Journal
Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
Previous Article in Journal
Prevalence, Characterization, and Mycotoxin Production Ability of Fusarium Species on Korean Adlay (Coix lacrymal-jobi L.) Seeds
Reply published on 27 October 2016, see Toxins 2016, 8(11), 312.
Open AccessComment

Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

1
Center of Pharmacology and Toxicology, Hannover Medical School, Carl-Neuberg-Str., Hannover 30625, Germany
2
National Institute of Nutrition and Seafood Research (NIFES), Nordnes, Bergen N-5817, Norway
*
Author to whom correspondence should be addressed.
Academic Editor: Joachim Jankowski
Toxins 2016, 8(11), 311; https://doi.org/10.3390/toxins8110311
Received: 23 May 2016 / Revised: 26 July 2016 / Accepted: 21 October 2016 / Published: 27 October 2016
Note: In lieu of an abstract, this is an excerpt from the first page.

Boelaert et al. [1] compared UPLC–MS/MS with ELISA assays for the determination of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), two endogenous inhibitors of nitric oxide (NO) synthesis [2], in serum of patients with chronic kidney disease (CKD) and healthy subjects.[...] View Full-Text
Show Figures

Figure 1

MDPI and ACS Style

Tsikas, D.; Beckmann, B.; Araujo, P. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149. Toxins 2016, 8, 311.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop